Table 2.
Treatment |
First Line Frequency (%) |
Second Line Frequency (%) |
Third Line Frequency (%) |
Watchful Waiting | 7 (3.6) | 1 (0.5) | 0 (0) |
Medical | |||
Oral Contraceptive | 105 (54) | 51 (28) | 3 (2.4) |
NSAID | 50 (26) | 8 (4.4) | 1 (0.8) |
Progesterone alone | 22 (11) | 33 (18) | 6 (4.8) |
Estrogen alone | 2 (1.0) | 0 (0) | 0 (0) |
Anti-fibrinolytic | 2 (1.0) | 2 (1.1) | 4 (3.2) |
Gonadotropin Agonist | 3 (1.5) | 6 (3.3) | 6 (4.8) |
Referral | 18 (9.3) | 88 (48) | 106 (84) |
Surgical | |||
Dilatation and Curettage | 6 (3.1) | 31 (17) | 10 (7.9) |
Endometrial Ablation | 1 (0.5) | 10 (5.5) | 13 (10) |
Hysterectomy | 2 (1.0) | 10 (5.5) | 25 (20) |
Total Respondents | 194 | 183 | 126 |